+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In whole blood ex vivo the human bactericidal permeability increasing protein and a recombinant amino terminal fragment cause killing of surviving gram negative bacteria and inhibit tnf release induced by the bacteria



In whole blood ex vivo the human bactericidal permeability increasing protein and a recombinant amino terminal fragment cause killing of surviving gram negative bacteria and inhibit tnf release induced by the bacteria



Clinical Research 40(2): 213A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031872648

Download citation: RISBibTeXText


Related references

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. Journal of Clinical Investigation 90(3): 1122-1130, 1992

Enhancement of neonatal innate defense Effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and TNF-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Pediatric Research 47(4 Part 2): 268A, 2000

Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Infection and Immunity 68(9): 5120-5125, 2000

Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infection and Immunity 63(1): 333-339, 1995

Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis. Journal of Infectious Diseases 171(1): 153-160, 1995

A recombinant amino terminal fragment of bactericidal/permeability increasing protein inhibit LPS-induced E-selectin mRNA expression in human endothelial cells. FASEB Journal 8(4-5): A234, 1994

Efficacy of a recombinant amino terminal fragment of bactericidal/permeability increasing protein in rodents challenged with LPS or E. coli bacteria. Progress in Clinical and Biological Research 388: 255-263, 1994

Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infection and Immunity 62(4): 1185-1191, 1994

Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis. Antimicrobial Agents and ChemoTherapy 40(1): 65-69, 1996

Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal/permeability-increasing protein. International Journal of Antimicrobial Agents 42(6): 571-574, 2013

A recombinant amino-terminal fragment of bactericidal/permeability increasing protein (rBPI23) inhibits soluble CD14-mediated lipopolysaccharide-induced endothelial adherence for human neutrophils. Shock 1(2): 81-86, 1994

Recognition of endotoxin and serum resistant bacteria in whole blood by bpi 23 a recombinant 23 kd lps binding fragment of bactericidal permeability increasing protein bpi. Journal of Cellular Biochemistry Suppl. (16 Part C): 161, 1992

Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties. Journal of Infectious Diseases 170(6): 1473-1482, 1994

Recombinant amino terminal fragment of bactericidal/permeability increasing protein prevents endotoxin-induced disturbances in carbohydrate homeostasis. FASEB Journal 7(3-4): A662, 1993

Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet (North American Edition) 350(9089): 1439-1443, 1997